Document type

Article

Version

Published version

Publication date

Publication license

cc by-nc-sa (c) Puig i Sardà, Susana et al., 2016
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/160523

Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

PURPOSE: CDKN2A is the main high-risk melanoma-susceptibility gene, but it has been poorly assessed in Latin America. We sought to analyze CDKN2A and MC1R in patients from Latin America with familial and sporadic multiple primary melanoma (SMP) and compare the data with those for patients from Spain to establish bases for melanoma genetic counseling in Latin America. METHODS: CDKN2A and MC1R were sequenced in 186 Latin American patients from Argentina, Brazil, Chile, Mexico, and Uruguay, and in 904 Spanish patients. Clinical and phenotypic data were obtained. RESULTS: Overall, 24 and 14% of melanoma-prone families in Latin America and Spain, respectively, had mutations in CDKN2A. Latin American families had CDKN2A mutations more frequently (P = 0.014) than Spanish ones. Of patients with SMP, 10% of those from Latin America and 8.5% of those from Spain had mutations in CDKN2A (P = 0.623). The most recurrent CDKN2A mutations were c.-34G>T and p.G101W. Latin American patients had fairer hair (P = 0.016) and skin (P < 0.001) and a higher prevalence of MC1R variants (P = 0.003) compared with Spanish patients. CONCLUSION: The inclusion criteria for genetic counseling of melanoma in Latin America may be the same criteria used in Spain, as suggested in areas with low to medium incidence, SMP with at least two melanomas, or families with at least two cases among first- or second-degree relatives.Genet Med 18 7, 727-736.

Subject (English)

Citation

Citation

PUIG I SARDÀ, Susana, et al. Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma. Genetics in Medicine. 2016. Vol. 18, num. 7, pags. 727-736. ISSN 1098-3600. [consulted: 17 of June of 2026]. Available at: https://hdl.handle.net/2445/160523

Export metadata

JSON - METS

Share record